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The cyclin-dependent kinase inhibitor p27
KIP1 is a tumor suppressor gene in mice, and loss of p27 protein is a negative
prognostic indicator in human cancers. Unlike other tumor suppressors, the p27 gene is rarely mutated in tumors.
Therefore misregulation of p27, rather than loss of the gene, is responsible for tumor-associated decreases in p27
protein levels. We performed a functional genomic screen in p27
þ/  mice to identify genes that regulate p27 during
lymphomagenesis. This study demonstrated that decreased p27 expression in tumors resulted from altered
transcription of the p27 gene, and the retroviral tagging strategy enabled us to pinpoint relevant transcription
factors. inhibitor of DNA binding 3 (Id3) was isolated and validated as a transcriptional repressor of p27. We further
demonstrated that p27 was a downstream target of Id3 in src-family kinase Lck-driven thymic lymphomagenesis and
that p27 was an essential regulator of Lck-dependent thymic maturation during normal T-cell development. Thus, we
have identified and characterized transcriptional repression of p27 by Id3 as a new mechanism decreasing p27 protein
in tumors.
Citation: Garrett-Engele CM, Tasch MA, Hwang HC, Fero ML, Perlmutter RM, et al. (2007) A mechanism misregulating p27 in tumors discovered in a functional genomic
screen. PLoS Genet 3(12): e219. doi:10.1371/journal.pgen.0030219
Introduction
p27
KIP1 binds to and thereby prevents cyclin-CDK com-
plexes from phosphorylating their protein substrates [1]. The
biological consequence of this molecular interaction in
cultured cells is cell cycle arrest, primarily in the G1 phase.
Analysis of p27
 /  mice provides further evidence that p27 is
an important regulator of cell proliferation in vivo. p27 null
mice exhibit gigantism and contain proportionally larger,
hypercellular organs compared to wild-type siblings [2]. The
p27-null thymus was disproportionately enlarged compared
to the whole animal, though developing thymocyte subsets
were maintained in normal proportions. Increased T-lineage
proliferation was also seen in the spleen [3]. Further analysis
demonstrated that p27 controls cytokine stimulated T-cell
proliferation [4,5]. In addition to the cell proliferation
phenotype, p27
 /  mice develop spontaneous pituitary ad-
enomas.
Analyses of tumor susceptibility demonstrated that the p27
gene is a dose-dependent tumor suppressor gene [6]. That is,
a 50% reduction in p27 protein levels was sufﬁcient to
predispose p27
þ/  mice to tumors in multiple organs,
especially following the administration of exogenous carci-
nogens, or when genetically combined with various onco-
genes or deletions of tumor suppressors. Thus, loss of p27
accelerated the rate of tumor development in p27
 / ;R b
þ/ ,
p27;pten, and p27
 / ;Apc
Minþ/  mice [7–9]. In different tumor
models, p27 deﬁciency increased both the number of tumors
and their rate of progression to more aggressive cellular
phenotypes [10].
In humans, decreased expression of p27 protein is a
negative prognostic indicator in breast, colon, prostate, lung,
esophageal, and gastric cancer [11]. Additionally, loss of p27
expression is one of the most clinically signiﬁcant negative
prognostic markers in human breast cancers [11], and its
prognostic value improves when combined with other
markers [12]. Although reduced p27 protein levels are
observed in tumors, both alleles of the p27 gene are rarely
mutated [11]. Therefore, the quantity of p27 protein appears
to mediate tumor susceptibility, and misregulation of p27
expression, rather than loss of its gene, is responsible for
decreases in p27 protein levels. For this reason, if the
pathways that cause p27 misregulation could be inhibited,
then the tumor suppressor function of p27 could potentially
be restored in cancer cells.
Although the regulation of p27 in normal cells occurs at
the transcriptional, translational, and post-translational
levels [13–18], most attention in cancer cells has focused on
p27 misregulation via ubiquitin-dependent protein degrada-
tion, speciﬁcally by the SCF-Skp2 E3 ubiquitin-protein ligase
[19]. Recently, we analyzed tumorigenesis in knock-in mice
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ubiquitinated by the SCF-Skp2 pathway. The p27T187A
protein was down-regulated in lung tumors induced by an
activated K-ras allele to the same extent as wild-type p27
protein, and moreover the p27
T187A mice had the same rate of
tumor-dependent death as p27 wild-type mice [20]. Addition-
ally, we observed a substantial decrease in p27 mRNA in these
lung tumors. These data imply that mechanisms other than
SCF-Skp2-mediated protein degradation play signiﬁcant
roles in misregulating p27 during tumorigenesis.
To elucidate the molecular mechanisms that contribute to
p27 misregulation during lymphomagenesis, we used a
functional genomics assay to identify genes that repress
p27. We discovered inhibitor of DNA binding 3 (Id3) as a
candidate negative regulator of p27 in our screen. Id3 is an
HLH protein that lacks a DNA binding domain and
antagonizes transcriptional activators by stably forming
heterodimers unable to bind DNA sequences within target
gene promoters and thus down regulates gene expression
[21]. We demonstrated that Id3 decreased p27 transcription
during lymphomagenesis and further established that Id3 was
part of the pathway by which the src-family protein tyrosine
kinase (PTK) p56
lck repressed p27 expression to stimulate
proliferation of T-cell progenitors in the thymus.
Results
Functional Genomic Assay of Lymphomas from p27
þ/ Mice
We used retroviral insertional mutagenesis to screen the
mouse genome for genes that modulate p27 protein levels
during tumorigenesis. Moloney murine leukemia virus (M-
MuLv) integrates throughout the genome and primarily up-
regulates nearby genes [22], which induces tumors in vivo and
tags the relevant oncogenes by their physical proximity to the
retrovirus. Wild-type, p27
 / , and p27
þ/  heterozygous mice
were infected with M-MuLv, which is tropic for the thymus
and therefore predominantly induced T-cell lymphomas.
Previously, it was demonstrated that after exposure to M-
MuLv the p27
þ/  heterozygous mice developed lymphomas at
an intermediate rate compared to the wild-type and knock-
out mice [23]. Therefore, given that the p27
þ/  heterozygotes
contain 50% as much p27 protein as wild-type mice [6], this
genotype may represent a sensitized background for reveal-
ing M-MuLv-induced changes in gene expression that caused
further reductions of p27 protein. Our strategy was to
identify the subset of tumors arising in p27
þ/  heterozygotes
that contained very low or undetectable quantities of p27
potentially resulting from insertional activation of genes that
down-regulated p27. Western analysis of 44 lymphomas
induced by M-MuLv in p27
þ/  mice showed that all of them
expressed lower amounts of p27 protein than did normal
p27
þ/ thymus. Indeed, 10/44 tumors had almost no detectable
p27 protein (Figure 1A). The uniformly lower amounts of p27
protein in lymphomas compared to normal thymus may be a
normal consequence of the increased proliferation character-
istic of many tumors. However, we hypothesized that the ten
lymphomas with undetectable amounts of p27 protein had
suffered an M-MuLv-mediated event that caused a further,
pathological reduction in p27 expression. From these ten
tumors, retroviral junction fragments were cloned by inverse
PCR and veriﬁed by DNA sequencing as legitimate M-MuLv-
genomic DNA junction fragments (see Materials and Meth-
ods). From these we identiﬁed 55 unique insertional junction
fragments (Table 1), which was in good agreement with the 53
retroviral insertions we had estimated on the basis of
Southern data from the tumors (unpublished data).
DNA sequences of the 55 cloned junction fragments were
analyzed using the National Center for Biotechnology
Information and the Celera mouse databases. Insertion sites
from at least two independent tumors that colocalized to
within a 125-kb genomic interval were designated as common
insertion sites (CIS). Our analysis revealed seven CIS (Table
2). The gene tagged most frequently in the p27
þ/  lymphomas
was myc (seven out of ten). Also, the C14 CIS [23] was found in
four of the ten tumors analyzed; myb, RORC, cux-1, CIS4, and
LDLR/Mc7 were each detected in two independent tumors. In
a large-scale retroviral insertional mutagenesis to identify
cancer genes, 62% of the CIS were found in only two tumors
[24]. Similarly, our data indicate 71% of the CIS in p27
þ/ 
mice were detected in two tumors. In addition to the above
CIS, two CIS deﬁned by insertions in or near different
members of a gene family were detected. Eya1 and Eya3, and
Wnt10b and Wnt16 were each identiﬁed in this way. We
categorized these as CIS because, although they were only
found near each gene a single time, they involved functionally
related members of a gene family. Single insertions in genes
within signaling cascades have been detected in other screens,
including the Wnt signaling pathway [24]. Finally, single
insertions in known CISs were identiﬁed for Jdp2, pim-1, Gﬁ,
rasgrp1, and Notch1 (Table 2).
The key question in our approach was how to sort among
the many retrovirally tagged genes for the candidates that
were most likely to participate in the regulation of p27. We
postulated that three types of genes would be tagged in our
screen: genes that modulated p27 levels; genes that were
oncogenic by mechanisms other than down-regulation of p27;
and genes that represented random, unselected sites of
retroviral integration. We tentatively assigned a tagged gene
to the ﬁrst, p27-regulatory category if it: (1) was tagged in
multiple independent tumors with low levels of p27 protein
expression and was therefore unlikely to represent a random,
unselected site of integration, and (2) it was not tagged in any
tumor arising in p27
 /  mice. Activation of a gene that down-
regulated p27 should provide no selective advantage to cells
already lacking the p27 protein. We compared the p27
þ/  CIS
in Table 2 to the CIS identiﬁed from 277 junction fragments
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Id3 Represses p27
Author Summary
Many human cancers express abnormally low amounts of the p27
protein, and this is associated with aggressive tumor behavior and a
poor clinical outcome. Surprisingly, the p27 gene is rarely mutated in
these tumors and retains the potential to produce normal amounts
of p27 protein. Therefore, understanding the pathways that cause
the decrease of p27 protein in cancer cells may lead to the
development of new therapies that restore p27 gene expression to
normal levels. We undertook a survey of the mouse genome to
identify genes that modulate p27 protein levels in lymphomas. Our
analysis discovered inhibitor of DNA binding 3 (Id3) as a negative
regulator of p27 gene expression. Additionally, we demonstrated
that the p27 gene is controlled by Id3 during normal embryological
development of the thymus. Our results underscore the fact that
cancer cells frequently exploit normal developmental pathways as
they evolve into increasingly aggressive transformed states.that were isolated in a similar manner from p27
 / lymphomas
[23]. Only CIS4 fulﬁlls our criteria for a regulator of p27
because it was deﬁned by insertions from two independent
lymphomas (Figure 1B), and insertions at CIS4 were not
found in lymphomas from p27
 / mice (p , 0.03). In addition
to CIS4, the CIS representing the Eyes Absent (Eya) family and
the CIS representing the Wnt family were not isolated from
p27
 /  mice. Therefore, while the Eya and Wnt genes may also
represent candidate negative regulators of p27, we focused
here on CIS4.
Id3 Is a Target of M-MuLv Activation in CIS4
CIS4 was previously isolated in ﬁve retroviral insertional
mutagenesis screens in p27 wild-type mice and designated
Evi62 (Retrovirus Tagged Cancer Gene Database). Evi62
insertions were mapped near the Id3 and E2F2 genes, but
the target gene of the retroviral insertions in Evi62 had not
been established. In addition to the Id3 and E2F2 genes, the
Ddeﬂ1, Tcea3, Zfp46, and Hnrpr genes mapped to the region
(Figure 1B). Since Id3 and E2F2 regulate the cell cycle, we
focused on these two as candidate genes. We used western
analysis to determine if Id3 or E2F2 was up-regulated by the
retroviral insertions in our tumors. Analysis of Id3 protein
levels in the lymphomas detected high Id3 expression in the
tumor with the retroviral insertion immediately adjacent to
the Id3 gene, and moderate Id3 expression in the other, more
distantly tagged tumor (Figure 1C). In total, four of the ten
lymphomas screened for CIS had high to moderate Id3
Figure 1. Analysis of M-MuLV Induced Lymphomas from p27
þ/  Mice
(A) Western analysis of p27 protein levels in p27 wild-type and p27
 / thymus tissues and 20 of the 44 p27
þ/ lymphomas. The blots were probed with a-
tubulin as a loading control.
(B) A schematic of the region on Chromosome 4 flanking the retroviral insertion sites is shown. The relative positions of Id3, E2F2, Ddefl1, Tcea3, Zfp46,
and Hnrpr are indicated.
(C) Id3 protein levels in a subset of the lymphomas from (A) p27
þ/  lymphomas. a-tubulin is shown as a loading control. The tumors with Id3 retroviral
insertions near Id3 are indicated with an asterisk. The lymphoma with M-MuLv insertion closest to Id3 has the highest level of Id3 protein.
doi:10.1371/journal.pgen.0030219.g001
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Id3 Represses p27expression (unpublished data). One of the tumors with
elevated Id3 protein had a retroviral insertion adjacent to
the Notch gene, which is a known activator of Id3 [25]. The
mechanism up-regulating Id3 in the fourth lymphoma was
not investigated further. In the other set of 34 lymphomas,
with higher expression of p27, 30% had low expression Id3,
and no Id3 expression was detectable in the others
(unpublished data). No increase in E2F2 protein was observed
in any of our tumors with the M-MuLV insertions (unpub-
lished data). Additionally, no effect on p27 transcription by
E2F2 was detected by DNA transcription array experiments
[26–28]. Therefore, our data suggest Id3 was the likely target
of the retroviral insertion at Evi62. In addition to Id3, other
genes in the region may also be activated by the retroviral
insertions and could potentially regulate p27 in coordination
with Id3; however, we analyzed Id3 alone as a negative
regulator of p27. In the experiments below, we tested whether
there was a causal relationship between Id3 up-regulation
and p27 down-regulation.
Since Id3 regulates transcription, we measured the p27
transcript levels in the lymphomas. Quantitative real time
(RT) PCR data revealed that p27 mRNA was reduced in all of
the p27
þ/ lymphomas relative to normal p27
þ/ thymus, with a
signiﬁcantly greater reduction in p27 mRNA abundance in
the set of lymphomas expressing very low or absent p27
protein (Figure 2A). Therefore, control of mRNA expression
appeared to be a general mechanism for decreasing p27
protein levels in these lymphomas. To determine whether Id3
regulates p27 transcript levels, we knocked down Id3
expression in NIH3T3 cells using Id3 siRNAs. Three concen-
trations of pooled Id3 siRNAs were transfected into cells, and
all siRNA concentrations increased p27 protein levels
compared to cells transfected with a nonspeciﬁc control
siRNA (Figure 2B). Quantitative RT-PCR on RNA isolated
from these cells conﬁrmed that Id3 mRNA decreased and that
p27 mRNA increased, dependent on the presence of the Id3
siRNA (Figure 2C). Thus, Id3 repressed p27 transcript levels
in NIH 3T3 cells.
Id3 Represses p27 Gene Expression
The HLH protein Id3 represses transcription by interact-
ing with transcription factors to form heterodimers unable to
bind DNA. Previous experiments demonstrated that coex-
Table 1. Retroviral Insertion Sites Identified in the p27
þ/ 
Lymphomas
Tumor Chromosome Location, Mb
4906 1 5.036
4752 1 147.166
4745 2 22.661
4745 2 165.316
4575 2 115.321
4665 2 100.201
4671 2 100.201
4745 2 26.709
4665 2 130.653
4803 3 86.409
4671 3 86.409
4803 4 135.423
4747 4 40.451
4747 4 135.301
4886 4 129.46
4803 5 129.786
4747 5 130.232
4745 5 28.012
4090 5 100.548
4752 5 116.875
4575 6 122.976
4752 6 18.707
4747 7 54.668
4747 7 13.911
4745 7 115.547
4803 8 113.839
4886 8 112.969
4745 9 108.593
4575 10 17.847
4906 10 17.972
4671 10 70.999
4803 11 2.543
4665 11 76.253
4752 11 70.134
4745 12 75.504
4665 12 9.895
4747 13 55.01
4747 13 79.49
4747 15 56.914
4575 15 58.621
4090 15 95.404
4090 15 56.914
4906 15 56.914
4886 15 56.914
4671 15 97.445
4671 15 57.139
4752 15 56.912
4745 17 25.96
4665 17 22.059
4886 18 69.697
4803 X 50.098
4747 X 50.097
4575 X 50.097
4906 X 50.097
4671 Unknown N/A
All 55 retroviral-genomic DNA junction fragments isolated from the ten p27
þ/  tumors
analyzed were mapped using the Celera and NCBI mouse genome databases. The tumor
number is listed with the chromosome the insertion site mapped to, and the Mb position
on the chromosome.
doi:10.1371/journal.pgen.0030219.t001
Table 2. Common Integration Sites in p27
þ/  Lymphomas
Category Gene Frequency
Genes Tagged Myc 7
C14 4
Myb 2
RORC 2
Cux-1 2
LDLR/Mc7 2
CIS4 2
Known CIS Pim-1 1
Gfi 1
Notch1 1
Rasgrp1 1
Jdp2 1
Gene Families Wnt 2
Eya 2
The genes near the retroviral insertion sites and the frequency of the insertions in the ten
tumors are indicated. In addition to genes tagged by more than one retroviral insertion,
previously defined CISs represented by one insertion in the p27
þ/  lymphomas are
included in the table. Gene families with more than one member tagged by the retrovirus
are listed. The CISs shown in bold are unique to the p27
þ/  genotype in our M-MuLv
mutagenesis.
doi:10.1371/journal.pgen.0030219.t002
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Id3 Represses p27pression of the bHLH proteins E12 and NeuroD2 led to
increased p27 protein in cells [29]. However, these experi-
ments did not address whether this increased p27 expression
was a direct or indirect effect of the bHLH proteins, nor
whether it occurred at the level of p27 transcription. The 2.0-
kb mouse p27 promoter contains six potential E-box
sequences (CANNTG). We tested the ability of bHLH
heterodimers to stimulate transcription from a full-length
p27 promoter-luciferase fusion gene and a minimal promoter
containing two of the six E-box sequences (Figure 3A). While
neither E12 nor NeuroD2 alone affected p27 promoter
activity (unpublished data) as expected [30], cotransfection
of increasing amounts of E12/NeuroD2 caused a dose-
dependent increase in both the full length and minimal p27
promoter activity (Figure 3B). Expression of the p27
promoter-luciferase fusion gene constructs was also stimu-
lated by E12/E47 heterodimers, which are bHLH proteins
expressed in lymphocytes (unpublished data). This activation
Figure 2. p27 Transcript Is Regulated in p27
þ/  Lymphomas and Normal Cells
(A) p27 transcript levels in p27
þ/  thymus and p27
þ/  lymphomas were determined by quantitative RT-PCR using probe and primer sequences at the
border of exons 1 and 2. The amount of RNA in each sample was normalized to HPRT1 gene expression. The fold change observed is relative to the p27
transcript levels in the p27
þ/ normal thymus indicated by the striped bar. The p27 low lymphomas from Figure 1A are shown in black, and lymphomas
with higher p27 protein are shown in gray. An asterisk marks lymphomas with retroviral insertions near Id3.
(B) p27 protein levels increase dependent on the presence of the Id3 siRNA. a-tubulin expression is shown as a loading control.
(C) Quantitative RT- PCR indicates Id3 siRNA decreased Id3 mRNA and increased p27 mRNA abundance. HPRT1 mRNA was used to normalize RNA
amounts in each sample. All primer-probe sets are located at exon borders.
doi:10.1371/journal.pgen.0030219.g002
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Id3 Represses p27was dependent on the presence of the two E boxes (CANNTG)
and one imperfect E box (GACCTG) in the p27 minimal
promoter, as the p27 minimal promoter with these sites
mutated to CGNNAT and GGCCAT respectively could only
be induced to 26% of the wild-type promoter (Figure 3C).
This residual induction was likely due to fortuitous E-box
sequences in the expression vector itself [31]. Furthermore,
titration of Id3 abrogated the stimulatory effect of E12/ND2
on the p27 minimal promoter (Figure 3D). The effect of Id3
was speciﬁcally to antagonize bHLH protein-stimulated
transcription, because in the absence of cotransfected bHLH
proteins, Id3 had almost no detectable effect on basal, low-
level p27 promoter expression (unpublished data). The results
of these experiments suggest that bHLH proteins directly
activate the p27 promoter and that Id3 represses p27
transcription by inhibiting bHLH protein function.
To further examine Id3 regulation of p27 in cancer cells, we
studied lymphoma cell lines in which the src-family protein
tyrosine kinase p56
lck could be conditionally regulated. p56
lck
activity increased Id3 transcript levels in cultured lympho-
cytes [32], and cell lines derived from lymphomas arising in
mice overexpressing p56
lck [33] provided a system to assay
Id3-mediated repression of p27. Cells were treated with a
pharmacologic inhibitor highly speciﬁc for src-family protein
tyrosine kinases, PP1 [34]. Analysis of Id3 mRNA abundance
by quantitative RT-PCR conﬁrmed that this transcript rapidly
declined 5-fold within 1 h following inhibition of p56
lck
activity. After Id3 expression declined and Id3 protein
disappears because of its short half-life [35], p27 mRNA
increased an average of 2-fold by 2 h (Figure 4A). A cell line
derived from thymic lymphomas arising in SV40 large T-
protein transformed mice was used as a control for PP1
speciﬁcity for p56
lck [36]. As expected if p56
lck is the kinase
required for modulating Id3 and p27 transcript abundance,
Id3 and p27 mRNA levels remained essentially unchanged
after addition of PP1 to these cells (Figure 4B), consistent
with the transformed phenotype of these cells being
independent of Lck activity. Thus, p56
lck activity was required
for maintaining Id3 mRNA expression and repressing p27
transcript levels.
We further showed that enforced Id3 expression rescued
p27 repression in lymphoma cells in cells treated with the
pharmacologic inhibitor of p56
lck. Lck-transformed cells
infected with an Id3-expressing retrovirus or control retro-
virus were treated with PP1 and assayed for Id3 and p27
transcript abundance. Cells transduced with the Id3 expres-
sion vector continued to express the Id3 mRNA at close to
physiological levels (.50%) after addition of PP1, and the p27
mRNA remained repressed (Figure 4C). The results from the
control retrovirus infected cells were indistinguishable from
the uninfected cells; the Id3 transcript was decreased 5-fold,
and the p27 transcript was increased almost 3-fold after
addition of PP1 (Figure 4A and 4D). Since Id3 acts as
transcription repressor, the p27 transcription rate was
examined using nuclear run-on assays. A rapid 3-fold
induction of p27 transcription was observed following
p56
lck inhibition and decreased Id3 expression, and the
converse transcriptional silencing of the p27 gene soon after
inhibitor removal and reactivation of p56
lck (Figure 4E).
These results demonstrate that Id3 was sufﬁcient to repress
accumulation of the p27 mRNA via a reduced rate of p27
transcription.
The increased p27 transcription that follows p56
lck inhib-
ition delayed progression through the cell cycle. Initially, Lck
inhibition resulted in depletion of early S-phase cells,
followed over time by an accumulation of cells with a 2N
(G1) content of DNA (Figure 4F). Removal of PP1 resulted in
a near-synchronous progression of the culture into S phase
(Figure 4F). Western-blot analysis of lysates from PP1-treated
cells showed a rapid accumulation of p27, its association with
cyclin E-containing complexes, and a loss of in vitro histone
kinase activity in immunoprecipitates containing cyclin E
(unpublished data). Conversely, following washout of PP1, p27
mRNA levels rapidly fell to baseline though the protein
remained elevated for an additional 12 h falling coincident
with induction of cyclin E-associated kinase activity and S-
phase entry (unpublished data). Therefore, the increased
transcription of p27 due to loss of Lck and Id3 activity
resulted in a reversible cell cycle arrest in lymphoma cells.
p56
lck and Id3 Regulate p27 during Thymocyte Maturation
To investigate the repression of p27 by Id3 and p56
lck in
vivo, we tested whether a genetic interaction could be
detected during normal thymic development in mice. Thymic
maturation is punctuated by differential induction and
silencing of CD4 and CD8 expression. The most immature
lymphoid cells are CD4
 CD8
  double-negative (DN) cells [37].
Within the DN compartment, expression of CD25 and CD44
further deﬁnes four subsets (DN1 through DN4) of increasing
maturity. The DN4 subset is the immediate antecedent to the
double-positive (DP) population [38]. Mice deﬁcient in p56
lck
have impaired DN3 to DN4 maturation and consequent
constriction of the DP compartment, resulting in hypocel-
lular thymi proportionately enriched in DN cells [39].
Similarly, overexpression of p27 also inhibits the DN3 to
DN4 transition in a dose-dependent fashion [40]. Therefore,
as observed in lymphoma cells Lck activity may repress p27
gene expression during thymocyte maturation.
As a test of whether p27 is downstream of Lck during
thymocyte maturation, p27
 /  mice were crossed to lck
 / 
mice, and the phenotypes of the progeny were analyzed for
rescue of the proliferative and developmental arrest caused
by the loss of Lck activity. The lck
 / p27
þ/  and lck
 / p27
 / 
animals displayed a proportionate and absolute expansion of
the DP compartment (Figure 5A), consistent with an increase
in either the number of cells maturing or proliferating, or
both. Also, total thymus cellularity progressively increased in
inverse relationship to p27 gene dosage, although it did not
Figure 3. Id3 Regulates Expression of p27 Promoter Reporter Construct
(A) A schematic of the full-length p27 promoter and a minimal p27 promoter are shown. The E-box sequences CANNTG are marked by asterisks.
(B) The E12/NeuroD2 E-protein heterodimers activate the full-length and minimal p27 promoters.
(C) The percent induction of the mutant p27 minimal promoter, with three of the four conserved bases in the E boxes mutated (CANNTG to CGNNAT), is
shown relative to the wild-type promoter.
(D) Id3 represses E-protein activation of the p27 minimal promoter. The SV40-b-galactosidase or CMV-b-galactosidase plasmids were used as an internal
control for each sample.
doi:10.1371/journal.pgen.0030219.g003
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Id3 Represses p27Figure 4. p56
Lck Regulates p27 Gene Expression Via Id3 in Lymphoma Cells
Quantitative RT-PCR detected transcript levels for Id3 and p27 in PP1 inhibited (A) Lck-expressing cells LGY-6871, (B) SV40–180 large T-protein
transformed cells, (C) LGY-6871 cells infected with an Id3 retrovirus, and (D) LGY-6871 cells infected with the control retrovirus are shown in the graph.
PP1 was added immediately after the time-0 timepoint was collected, and later aliquots were collected at the specified times. The Id3 probe and
primers detect endogenous and retroviral expressed Id3. HPRT1 gene expression was used to normalize each sample. The fold change in transcript
levels is relative to the 0 timepoint.
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Id3 Represses p27reach wild-type numbers (Figure 5B). This reﬂected a
numeric expansion of both the DN and DP compartments,
with proportionately greater increase in the latter. Addition-
ally, the DN compartment in the lck
 / p27
 /  mice appeared
enriched in the DN4 subset, indicative of a reduced threshold
for DN3 to DN4 progression (unpublished data). Thus loss of
p27 partially rescued the defects in lck
 /  mice. If Lck
repressed p27 through Id3, we would expect increased levels
of Id3 at the time p27 transcript is reduced. We compared p27
and Id3 transcript levels in small DN3 cells and DN4 cells
from wild type mice. As cells transitioned to the DN4 stage
p27 mRNA decreased 3-fold compared to the DN3 stage, and
Id3 mRNA increased 1.3-fold (Figure 5C). Therefore, as
observed in the lymphoma cells, there was a correlation
between decreasing p27 transcript levels and increasing Id3
transcript levels, suggesting that Id3 repressed p27 gene
expression at the DN3 to DN4 transition. These results
extend our molecular observations connecting Lck and p27
through the action of Id3 in lymphoma cells to normal
thymocyte development.
Discussion
We describe a functional genomics assay employing M-
MuLv insertional mutagenesis screen to detect negative
regulators of a tumor suppressor gene. We analyzed
lymphomas from p27
þ/  mice and discovered Id3 as a
repressor of p27 in cancer cells. Since the Id3 CIS was
detected in p27
þ/  tumors with low p27 protein, we propose
Id3 contributed to lymphomagenesis by causing the observed
decrease in p27 protein. Consistent with Id3 functioning as a
transcriptional repressor, p27 mRNA amounts were greatly
reduced in the tumors with Id3 tagged by the retrovirus.
Although decreases in p27 transcription in tumors or cancer
cell lines have not been widely reported, the predisposition of
p27
þ/  mice to tumors demonstrates a 50% reduction in p27
mRNA levels is physiologically relevant. Moreover, we
previously observed signiﬁcantly reduced p27 transcript in a
murine lung tumor model and in a subset of human breast
cancers [20]. Therefore, decreased p27 mRNA abundance may
occur in multiple types of cancer, and our isolation of Id3 as a
negative regulator of p27 implies a novel mode of regulation
for p27 in lymphomas.
In agreement with transcriptional regulation of p27
decreasing p27 protein in tumors, all of the p27
þ/ lymphomas
with low p27 protein analyzed for CIS had reduced levels of
p27 mRNA. In addition to Id3, we identiﬁed single speciﬁc
insertions in p27
þ/  mice near Wnt10b and 16 as well as Eya1
and 3. Cofactors of Eya proteins and Wnt1 repress p27
transcription [41,42]. In total, among the ten lymphomas in
which we were able to document very low p27 protein and
mRNA expression, seven had either up-regulated Id3 protein
or retroviral insertions near the Wnt or Eya genes. Two of the
remaining lymphomas had insertions in the Myb locus. The
p27 promoter contains a Myb binding site [43], and Myb
collaborates with Hes1, a known negative regulator of p27
[44]. However, the Myb CIS was also found in lymphomas
arising in p27
 /  mice. Thus, if Myb is a negative regulator of
p27 it is also likely to have p27-independent effects on
tumorigenesis. Therefore, transcription factors or cofactors
were identiﬁed in nine out of the ten tumors; however, Id3
represented the sole CIS not found in p27
 /  lymphomas.
Id3 and p27 have opposing effects on proliferation and
differentiation. Overexpression of Id1–3 genes increased cell
proliferation, and antisense Id1–3 delayed reentry of arrested
cells into the cell cycle [45], whereas increased p27 protein
arrests cells in G1. Also, overexpression of Id1 and Id2 in the
thymus promotes the development of lymphomas [46,47]. In
Id1
 / Id3
 / knockout mice, neuroblasts prematurely withdraw
from the cell cycle and p27 protein levels are elevated [48]
consistent with our luciferase assay data that Id3 regulates
p27 transcription via interference with neural bHLH pro-
teins. Additionally, in a wound healing model, Id3 repressed
ELK1 activation of p27 gene expression [49]. Furthermore,
inverse mRNA expression patterns of p27 and Id3 have been
observed in cells [50]. Increased Id3 and decreased p27
protein levels were observed when an oncogene was trans-
fected into cells [51]; however, a function for Id3 regulating
p27 in tumorigenesis was not investigated. Although regu-
lation of p27 transcription has been reported by Id3 in wound
healing [49] and other transcription factors in cell culture
[18], our results offered the ﬁrst evidence that Id3 directly
regulated p27 transcription in cancer cells, and moreover
indicated that, in vivo, it could cause the misregulation of p27
during tumorigenesis.
The variety of mechanisms controlling transcriptional
misregulation of p27 in human cancers remains to be fully
investigated. Id3 is overexpressed in many cancer types [52],
and loss of p27 is a signiﬁcant negative prognostic indicator
for many types of human cancers [11]. Furthermore, analysis
of human leukemias by DNA microarrays found increased Id3
gene expression and decreased p27 gene expression in the
samples (Ross_Leukemia and Schmidt_Leukemia, Onco-
mine database [53]). Therefore, Id3 misregulation of p27
transcription may be an important mechanism in human
cancers.
Our data demonstrating the control of p27 transcription as
a central mode of regulation downstream of Lck suggested
p27 may be regulated similarly in normal developmental
processes dependent on p56
lck signaling, including b-selec-
tion [54]. The role of bHLH/Id proteins in lymphoid
development is well established [30]. However, the genes
regulated by bHLH/Id proteins during b-selection remain
unknown. Previously, a cell cycle defect was observed in
E2A
 / lymphocytes when the bHLH protein E47 was added to
these cells, a phenotype that could indicate increased p27
expression [30]. Other observations also suggest p27 may be
regulated by the bHLH/Id proteins during b-selection.
Speciﬁcally, that DN4 cells had reduced p27 expression
compared to small, quiescent DN3 cells [55], and impaired
DN3 to DN4 maturation was seen with increasing dosage of
transgenic p27 expression [40]. Our data conﬁrmed that p27
(E) Representative autoradiograph of nuclear run-on assays from PP1 inhibited Lck-expressing cells LGY-10442–2 is shown and quantitative data from
three experiments. The p27 transcript levels were normalized to EF1a transcript levels. PP1 was added to the culture after the 0 timepoint and washed
out after 6 h as indicated by the arrow.
(F) FACS analysis of PP1-inhibited Lck-transformed lymphoma cells LGY-10442–2. The cells were treated as described for (E). The arrow indicates
depletion of early S-phase cells
doi:10.1371/journal.pgen.0030219.g004
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Id3 Represses p27transcript was decreased in DN4 cells relative to DN3 cells
and correlated the p27 mRNA decrease with increased Id3
mRNA at the DN3 to DN4 transition. Therefore, we
concluded p27 may be a critical target of regulation by Lck
through Id3 during thymic b-selection.
We further observed that in a gene-dosage fashion, p27
þ/ 
and p27
 /  partly relieved the lck
 /  phenotype, augmenting
the efﬁciency of DN to DP maturation and consequent
thymus cellularity. That the DN compartment expanded in
absolute cell numbers was an unexpected observation and
may reﬂect more developmental niches available throughout
the thymus, as the thymic epithelium increases in response to
both maturation and expansion of the lymphoid compart-
ment [56,57] as well as a consequence of the p27 mutation
[58]. In more preliminary studies, we examined the effect of
p27 mutation on the absolute block in development in a lck/fyn
double mutant (M. Tasch and R. Perlmutter, unpublished
observations). The residual thymic maturation in the lck
mutant is due to functional redundancy between Lck and a
related Src-family kinase, Fyn, and loss of both p56
lck and
p59
fyn results in severe thymic hypocellularity and devel-
opmental arrest at the DN3 stage. Here, p27
 /  relieved the
Figure 5. Loss of p27 Rescues the lck
 /  Phenotype
(A) Representative FACS analysis of thymi from lck
 / p27
þ/þ, lck
 / p27
þ/ , and lck
 / p27
 /  mice indicating loss of one copy of the p27 gene rescues the
lck
 /  phenotype.
(B) The total cellularity for thymi and DP cells from all three genotypes are shown in the graph. Data were collected from three lck
 / p27
þ/þ, seven
lck
 / p27
þ/ , and seven lck
 / p27
 /  mice.
(C) Quantitative RT-PCR detected transcript levels for Id3 and p27 in wild-type small DN3 and DN4 cells. The fold change in the mRNA levels in the DN4
cells is relative to the DN3 cells.
doi:10.1371/journal.pgen.0030219.g005
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Id3 Represses p27DN3 arrest and allowed accumulation of a DN4 compart-
ment. In parallel, very low level of expression for CD4 and
CD8 was observed, consistent with thymocytes making the
initial step in the DN to DP transition. However, this
maturation was abortive as bona ﬁde DP cells failed to
accumulate. These results are consistent with p27 being a
critical target of Lck signaling during thymic maturation, but
also indicate that Lck has targets in addition to p27 that are
essential for full thymic maturation.
In conclusion, our novel retroviral insertional mutagenesis
screen discovered a repressor of the tumor suppressor p27,
and our subsequent analysis identiﬁed transcriptional mis-
regulation of the p27 gene by Id3 as a new mechanism
controlling p27 levels in lymphomas. This study highlights the
fact that developmental pathways that regulate gene expres-
sion in normal cells are often coopted during tumor cell
evolution. Thus, Id3 is an essential downstream target of Lck
during normal thymic maturation and is activated to drive
p27 down-regulation in Lck-driven thymic lymphomas.
Finally, having demonstrated the importance of misregulat-
ing p27 at the level of gene transcription during lymphoma-
genesis, it now becomes crucial to understand which
transcriptional pathways cause misregulation of p27 in
human cancers, and how frequently this occurs.
Materials and Methods
Mice and M-MuLV mutagenesis. M-MuLv infection and genotyping
of the p27
þ/  mice was previously described in [23]. Animals were
euthanized when they developed signs of morbidity, and the
lymphomas were snap frozen in liquid nitrogen at necropsy. For
thymus analysis, p27
 /  mice on the 129 background were mated to
lck
 /  mice maintained on the C57BL/6 background, and the
compound heterozygous F1 mice were then backcrossed with lck
 / 
animals. The lck
 / p27
þ/  mice were mated with either lck
 / p27
þ/  or
lck
 / p27
 /  mice and the thymi from lck
 / p27
þ/þ, lck
 / p27
þ/ , and
lck
 / p27
 /  progeny analyzed. Mice carrying targeted disruptions of
the p27 and lck genes, and the procedures and reagents used in
genotyping, have been described previously [3,39].
Western blotting. Small pieces of normal thymus from wild-type
mice and lymphomas from p27
þ/  mice were homogenized in lysis
buffer (13 PBS, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, 1
mM dithiothreitol, 10 mM sodium ﬂouride, 1 mM sodium orthova-
nadate, 10 lg/ml leupeptin, 10 lg/ml aprotinin, 10 lg/ml pepstatin-A,
and 1 mM phenylmethylsulfonylﬂuoride). NIH 3T3 cells were lysed in
the same buffer as above. Samples were sonicated, and protein
concentrations were determined using the Bio-Rad protein assay. A
total of 40 lg of protein was separated on 12% SDS-PAGE gels, and
the proteins were transferred onto polyvinylidene diﬂouride mem-
branes (Perkin Elmer). The membranes were blocked in 13PBS, 0.1%
Tween-20, and 5% milk. After blocking, the membranes were
incubated with primary antibodies diluted 1:1,000 in 13 PBS, 5%
milk, and 0.1% Tween-20 overnight at 4 8C. Id3 (C-20) and p27 (C-19)
rabbit polyclonal antibodies from Santa Cruz Biotechnology and the
a-tubulin (clone DM1A) mouse monoclonal antibody from Sigma
were used. ECL (Amersham) was used for immunodetection.
DNA isolation and inverse PCR. Genomic DNA was isolated from
44 p27
þ/  lymphomas and inverse PCR performed as previously
described [23]. After two rounds of I-PCR the products were gel
puriﬁed and cloned using the Topo cloning system (Invitrogen)
following manufacturers protocol. Plasmids were sequenced using
M13–20 or M13 reverse primers and sequencing reactions were
carried out at the FHCRC automated sequencing shared resource.
The DNA sequence data were blasted against the NCBI, Celera, and
Ensembl mouse databases. The statistical signiﬁcance of the CIS4
retroviral insertions in the p27
þ/  versus the absence in the p27
 / 
lymphomas was determined using Fisher’s exact test at http://www.
exactoid.com/ﬁsher/index.php.
Tissue culture and retroviral infections. HEK 293T and Phoenix
ecotropic cells were grown in Dulbecco’s modiﬁed Eagle medium
(DMEM) containing 10% bovine growth serum (Hyclone), 1mM
sodium pyruvate, 2 mM L-glutamine, and 2 lg/ml penicillin-
streptomycin (Life Technologies). NIH 3T3 cells were grown in same
medium as above with the exception of 10% fetal bovine serum
(Hyclone). Thymic lymphoma cell lines LGY-6871, LGY-10442–2, and
SV40–180 were maintained in RPMI 1640 supplemented with 10%
fetal bovine serum, 2 mM L-glutamine, 0.1 mM nonessential amino
acids, 50 U/ml penicillin G, and 50 lg/ml streptomycin, 2.0 mM
HEPES buffer (pH 7.4), and 100 lM b-mercaptoethanol. All cell lines
were maintained at 37 8Ci n5 %C O 2.
For retroviral infections, the mouse Id3 cDNA (provided by B.
Christy) was cloned into the pQCXIP vector (BD-Clontech). Ecotropic
Phoenix cells were transfected with 15 lg pQCXIP-Id3 or pQCXIP
using Fugene 6 (Roche). After 24 h the medium was changed to
cRPMI, and the cells were moved to 34 8C. The LGY-6871 cells were
plated in a 10-cm dish and allowed to recover 4 h before infection.
The viral supernatant was collected 48 and 72 h after transfection and
passed through a 0.22-lm ﬁlter onto the LGY-6871 cells and 1 lg
polybrene added. The infections were done at 34 8C. Twenty-four
hours after the last infection the cells were centrifuged at 1,000 rpm
for 5 min, and the pellets resuspended in cRPMI medium and moved
to 37 8C. Selection with 0.5 lg/ml puromycin (Calbiochem) began 48 h
after infection for 4 d. Western analysis conﬁrmed the expression of
Id3.
RNA isolation and RT-PCR. RNA was extracted from pieces of
frozen lymphomas, normal thymi, normal thymocytes, NIH3T3 cells,
or thymic lymphoma cells LGY-6871 and SV40–180 following the
Trizol protocol (Invitrogen). cDNAs were generated by reverse
transcribing 1 lg of total RNA using oligo dT and the Taqman
reverse transcription kit (Applied Biosystems). The cDNAs were
diluted 1:10, and 5 ll added to each reaction containing Taqman
master mix at 13concentration and the p27 Mm00438167_g1, Hprt1
Mm00446968_m1, Id3 Mm00492575_m1, or Id3 Mm01188138_g1
Assay on Demand primers and probe (Applied Biosystems). Each 50-
ll reaction was done in triplicate. The Taqman analysis for the PP1-
inhibited cells was performed on two to three separate experiments.
Taqman RT-PCR reactions were performed using an ABI PRISM
7900HT sequence detector and analyzed by the SDS2.2 software.
Probe sequences were as follows:
Mouse p27: AGGAAGCGACCTGCTGCAGAAGATT
Mouse HPRT: AGGTTGCAAGCTTGCTGGTGAAAAG
Mouse Id3: GGCACCTCCCGAACGCAGGTGCTGG
Mouse Id3: CCGATCCAGACAGCTGAGCTCACTC
siRNA transfections. NIH 3T3 cells were transfected with 20 nM,
35 nM, or 50 nM pooled Id3 siRNA duplexes or siControl
nontargeting siRNA duplexes (Dharmacon) using siLentfect lipid
(Bio-Rad) according to the manufacturer’s protocol. Cells were
harvested for RNA isolation or protein lysates 24 h after transfection.
Luciferase and b-Galactosidase assays. The mouse p27 promoter
constructs were generated by cloning a 2.2-kb BamHI-BspEI fragment
or a 550-bp SacI-BspEI fragment into the pGL-2 luciferase vector
(Promega). The mouse E12 and mouse NeuroD2 plasmids were
provided by S. Tapscott and J. Olson, respectively. The internal
control plasmids were SV40-b-galactosidase or CMV-b-galactosidase,
and the CMV-luciferase plasmid was used as a positive control.
HEK293T cells were plated on 60-mm dishes, transfected using
calcium chloride method or Fugene 6(Roche), and harvested 48-h
after transfection for assays. Each transfection experiment was
repeated three to four times to ensure reproducibility. The luciferase
assays using Steady-Glo luciferase substrate (Promega) and b-
Galactosidase enzyme assay system (Promega) were used according
to manufacturers protocol. An EG&G plate reader was used for all
luciferase experiments, and a Labsystems Multiskan Plus plate reader
was used for the b-Galactosidase assays. Each luciferase and b-
Galactosidase reaction was done in triplicate and the data averaged.
Site-directed mutagenesis. E boxes 1 and 2 and the imperfect E box
were mutated to CGNNAT and GGNNAT using the QuikChange
Multi Site-Directed Mutagenesis kit (Stratagene) following the
manufacturer’s protocol. Primer sequences were as follows:
Ebox1: GCCCTCCAGTACGCTATATCACTGAAGCCTCGAG
Ebox2: CCTGGCTCTGCTCCGTTATACTGTCTGTGTGCAGTCG
I E box: GCCTCTCTTCCCCAGGCCATCGCGCTACTGCG
Lck-inhibition. The src-family–speciﬁc tyrosine kinase inhibitor
PP1 (Biomol) was used in in vitro cultures at 5 mM, diluted from a 5-
mM stock in DMSO directly into LGY-6871, LGY-6871þId3, LGY-
6871þpQCXIP, or SV40–180 cultures. Aliquots were removed from
cultures at indicated time points, washed in cold PBS, and cell pellets
either (1) snap frozen and maintained at  80 8C for later protein
extraction, (2) immediately resuspended in Trizol for subsequent
RNA extraction, (3) used immediately for DNA staining, or (4)
prepped for nuclei isolation.
DNA content analysis. LGY experimental and SV40 control cells
PLoS Genetics | www.plosgenetics.org December 2007 | Volume 3 | Issue 12 | e219 2425
Id3 Represses p27were washed in cold PBS and resuspended in a solution of 4.0 mM
sodium citrate (Sigma), 30 U/ml RNase, 0.1% Triton X-100 (Sigma),
and 50 mg/ml propidium iodide (Sigma). Cells were incubated at 37
8C in the dark for 10 min, after which 1/10 volume of 1.38 M sodium
chloride was added. Cells were then analyzed using a FACScan ﬂow
cytometers (Beckton-Dickenson) and Cell Quest (Beckton-Dickenson)
analysis software.
Transcription run-on analysis. Intact nuclei from LGY experimen-
tal and SV40 control cells were isolated in hypotonic Tris buffer
containing 0.25% nonident P-40 (Sigma), and nascent mRNA
transcripts were radiolabeled by incubation in buffer containing 60
mM each ATP, CTP, GTP, and 20 ml a
32P-UTP (4,000 Ci/mmol) [59].
Nuclei were treated with RNase-free DNase and proteinase K, and
RNA was isolated by phenol:chloroform extraction and ethanol
precipitation. Target DNA was linearized and denatured prior to
immobilization on polyvinylidene ﬂuoride (PVDF) membranes
according to the manufacturer’s instructions (Schleicher and
Scheull). Target sequences included pBluescript (SK) (Stratagene),
murine p27 cDNA, and murine elongation factor1a (EF1a) cDNA.
Hybridization was carried out for 18 h at 65 8C, and subsequently
membranes were washed stringently and exposed to autoradiography
media and quantitated by phosphorimage analysis.
Flow cytometry. Thymus tissue from lck
 / p27
þ/þ,l c k
 / p27
þ/ ,
and lck
 / p27
 /  mice was harvested after euthanasia, and single-cell
lymphocyte suspensions prepared by mechanical disruption with
scalpel followed by maceration with frosted glass slides. Cell
preparations were washed with cold PBS and red blood cells depleted
with hypotonic ammonium chloride per published protocols. Anti-
bodies speciﬁc for murine CD4, CD8, CD44, and CD25 and conjugated
to ﬂuorescein isothiocyanate (FITC), R-phycoerytherin (PE) or biotin,
and streptavidin conjugated to PE-Cy5 were obtained from BD/
Pharmingen and used at empirically derived concentrations on
samples of 1 3 10
6 cells. Staining buffer consisted of PBS with 5%
FCS, 5 mM HEPES buffer (pH 7.4), and 1 mM sodium azide. After
staining and extensive washing, cells were ﬁxed in 2% paraformalde-
hyde and analyzed with a FACScan ﬂow cytometers and Cell Quest
software (both Beckton-Dickenson). To isolate DN3 and DN4 cells for
mRNA, cells were sorted using a FACS ARIA ﬂow cytometer and
FACSDiva software (both products from Beckton Dickinson) on the
basis of CD44 and CD25 expression and cell size, as determined by
forward light scatter characteristics. Sorted cells were then disrupted
and extracted for total RNA as detailed above.
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